HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-12-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ultrasound represents a promising technique for the assessment of joint health in persons with haemophilia (PWH) by non-imaging specialists. The Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) programme has been developed with the aim of integrating joint ultrasound in the routine assessment of PWH through the use of a simplified scoring system. The inter-operator reliability of the technique among European haemophilia treaters has been validated and described elsewhere. Further work is needed to assess the real-world impact of ultrasound on disease management and treatment decision-making.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis

NCT06816953

Hemophilia A

ENROLLING_BY_INVITATION NA

The Hemophilia Ultrasound Project

NCT02807753

Hemophilia A Hemophilia B

TERMINATED

Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination

NCT04133883

Hemophilia A

COMPLETED NA

Handheld Ultrasound (HHUS) for Home Use in Hemophilia

NCT04131920

Joint Bleed Hemophilia A

COMPLETED

Ultrasonography in Hemophilic Joint Disease and Serum Markers

NCT02634918

Hemophilia A Hemophilia B Hemarthroses

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are seen routinely in clinic by specialist haemophilia physiotherapists who assess the patients using the Haemophilia Joint Health Score tool (HJHS). Trial participants will be seen during their routine clinic visits and will be seen by a clinician and the physiotherapist who will carry out the routine assessment along with the HEAD-US scan.

Patients will be seen a maximum of 4 times throughout the year from registration of the first patient, according to their visit schedule, but will only be scanned at the first visit.

Results will be analysed to determine if the treatment decision-making is influenced by the results of the scan

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moderate and Severe Haemophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single

All patients will undergo ultrasound scan using the HEAD-US Scoring System by a non-imaging specialist

Group Type EXPERIMENTAL

HEAD-US scoring system

Intervention Type OTHER

HEAD-US scoring system - Ultrasound scan performed by a non-imaging specialist to assess for joint bleed or damage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.